Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Rank in Stocks #31190
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Share Price
$0.03808538
Market Cap
$14.04M
Change (1 day)
-3.57%
Change (1 year)
6.63%
Country
AU
Trade BCAL Diagnostics Limited (BDX)

Category

Stock price history for BCAL Diagnostics Limited (BDX)
Highest end of day price: $0.04 on 2026-08-01

Lowest end of day price: $0.15 on 2021-07-01
Stock price history of BCAL Diagnostics Limited from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -14.06%
2025 6.49%
2024 -5.30%
2023 59.08%
2022 -54.80%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$588.85 20.78%
US
$201.05 -3.81%
US
$24.23 79.49%
CN
$313.02 94.24%
US
$557.51 -12.60%
US